The relevance of polymeric synthetic membranes in topical formulation assessment and drug diffusion study

Archives of Pharmacal Research
Shiow-Fern NgGillian M Eccleston

Abstract

Synthetic membranes are composed of thin sheets of polymeric macromolecules that can control the passage of components through them. Generally, synthetic membranes used in drug diffusion studies have one of two functions: skin simulation or quality control. Synthetic membranes for skin simulation, such as the silicone-based membranes polydimethylsiloxane and Carbosil, are generally hydrophobic and rate limiting, imitating the stratum corneum. In contrast, synthetic membranes for quality control, such as cellulose esters and polysulfone, are required to act as a support rather than a barrier. These synthetic membranes also often contain pores; hence, they are called porous membranes. The significance of Franz diffusion studies and synthetic membranes in quality control studies involves an understanding of the fundamentals of synthetic membranes. This article provides a general overview of synthetic membranes, including a brief background of the history and the common applications of synthetic membranes. This review then explores the types of synthetic membranes, the transport mechanisms across them, and their relevance in choosing a synthetic membrane in Franz diffusion cell studies for formulation assessment purposes.

References

Mar 1, 1975·The Journal of Investigative Dermatology·T J Franz
Oct 1, 1992·Clinical Pharmacokinetics·R C Wester, H I Maibach
Dec 1, 1992·Journal of Pharmaceutical Sciences·S T WuJ P Skelly
Jan 1, 1991·Pharmaceutical Research·V P ShahJ P Skelly
Dec 1, 1990·Chemical & Pharmaceutical Bulletin·T HatanakaY Morimoto
Jun 1, 1989·Journal of Pharmaceutical Sciences·D R FriendM Okagaki
Jun 1, 1988·Journal of Pharmaceutical Sciences·J N Twist, J L Zatz
Aug 1, 1987·Pharmaceutical Research·W J AddicksN Weiner
Oct 20, 1972·Science·R L FleischerR M Walker
May 1, 1969·Journal of Pharmaceutical Sciences·R E DempskiA W Wase
May 1, 1969·Journal of Pharmaceutical Sciences·B M PhillipsJ L Leeling
Sep 1, 1995·Journal of Pharmaceutical Sciences·V P Shah, J S Elkins
Feb 23, 1999·Pharmaceutical Development and Technology·M C BonferoniC Caramella
May 5, 1999·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·W DiembeckW Steiling
May 20, 1999·International Journal of Pharmaceutics·M DiasC Toscano
Aug 6, 1999·Pharmaceutical Development and Technology·V P ShahR L Williams
Apr 1, 2000·Journal of Controlled Release : Official Journal of the Controlled Release Society·P ClémentJ P Marty
Aug 5, 2000·Journal of Controlled Release : Official Journal of the Controlled Release Society·J Liaw, Y Lin
Jun 1, 2001·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·K Welin-BergerB Bergenståhl
Aug 4, 2001·Pharmaceutical Development and Technology·S ProniukJ Blanchard
Dec 4, 2003·International Journal of Pharmaceutics·Simon J GallagherCharles M Heard
Jun 9, 2005·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Vinod P Shah
Apr 8, 2006·International Journal of Pharmaceutics·Charles M HeardChris P Thomas
May 25, 2006·Drug Development and Industrial Pharmacy·Lucia MontenegroGiovanni Puglisi
Apr 22, 2009·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Matias Rauma, Gunnar Johanson
Mar 17, 2010·Journal of Pharmaceutical and Biomedical Analysis·J BoonenB De Spiegeleer
Aug 26, 2010·Pharmaceutical Development and Technology·Iman I SolimanEbtsam M Abdou
Sep 8, 2010·Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Société Canadienne Des Sciences Pharmaceutiques·Bram BaertBart De Spiegeleer

❮ Previous
Next ❯

Citations

Aug 21, 2013·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Laura J WatersJohn Stephenson
Jan 29, 2014·Drug Development and Industrial Pharmacy·P K RubyDeepika Aggarwal
Jul 9, 2013·Expert Opinion on Drug Metabolism & Toxicology·Sarah KüchlerWolfgang Friess
Jun 26, 2015·Journal of Pharmaceutical Sciences·Sahar AwwadPeng T Khaw
Feb 21, 2016·Colloids and Surfaces. B, Biointerfaces·L J Waters, A K M M H Bhuiyan
Jun 1, 2014·International Journal of Pharmaceutics·Eneko LarrañetaRyan F Donnelly
May 3, 2016·Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society·Danhua LiuDan Yang
Jun 19, 2013·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Judith KuntschePatrick Garidel
Mar 22, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Eleni TsanaktsidouCatherine K Markopoulou
Oct 10, 2020·Assay and Drug Development Technologies·Madhur KulkarniAditya Marfatiya
Jan 12, 2021·AAPS PharmSciTech·Catheleeya MekjaruskulXiuling Lu
May 24, 2020·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Sahar AwwadSteve Brocchini

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.